ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,180.74
      1.03%
      US Tech 100
      17,599.60
      1.04%
      Dow Jones
      38,852.27
      0.46%
      Brent Oil
      83.455
      -0.02%
      Bitcoin
      63,679.77
      0.81%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. VBI Vaccines Inc (VBIV)

      7. VBI Vaccines Inc (VBIV) News

      VBIV

      VBI Vaccines (VBIV)

      VBI Vaccines Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VBIV
      DateTimeSourceHeadlineSymbolCompany
      04/16/20248:00AMBusiness WireVBI Vaccines Reports Full Year 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
      04/11/20244:05PMBusiness WireVBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
      04/09/20242:45PMBusiness WireVBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
      04/03/20248:00AMBusiness WireVBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent GlioblastomaNASDAQ:VBIVVBI Vaccines Inc
      04/02/20248:00AMBusiness WireVBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine PlatformNASDAQ:VBIVVBI Vaccines Inc
      02/14/20248:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      02/14/20247:00AMBusiness WireVBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii BiosciencesNASDAQ:VBIVVBI Vaccines Inc
      02/06/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      01/23/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      01/11/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      12/26/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      12/12/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      11/29/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      11/20/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      11/20/20238:00AMBusiness WireVBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:VBIVVBI Vaccines Inc
      11/14/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      11/14/20234:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
      11/14/20234:05PMBusiness WireVBI Vaccines Reports Third Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
      11/03/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      10/26/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      10/26/20238:00AMBusiness WireVBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine ProgramNASDAQ:VBIVVBI Vaccines Inc
      09/27/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      09/27/20237:30AMBusiness WireVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of ConcernNASDAQ:VBIVVBI Vaccines Inc
      09/07/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      09/07/20238:00AMBusiness WireVBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBMNASDAQ:VBIVVBI Vaccines Inc
      09/06/20239:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      09/06/20238:00AMBusiness WireVBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis BNASDAQ:VBIVVBI Vaccines Inc
      08/14/20238:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
      08/14/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
      08/14/20238:00AMBusiness WireVBI Vaccines Reports Second Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
       Showing the most relevant articles for your search:NASDAQ:VBIV